The Global Market for Generative Biology 2024-2035

Description

List of Tables

Generative biology is an emerging field that leverages computational techniques, such as deep learning and evolutionary algorithms, to model, simulate, and engineer biological systems. This includes the generation, optimization, and analysis of biological structures, functions, and behaviours. The global generative biology market has experienced significant growth in recent years, driven by advancements in various computational approaches and the increasing recognition of their potential to accelerate innovation and product development across multiple industries. This report provides a comprehensive analysis of the current state and future trajectory of this dynamic market, spanning key technologies, applications, end-user industries, and regional trends.

Generative biology, an interdisciplinary field that integrates computational modelling, data science, and biotechnology, has emerged as a game-changer across diverse industries. From accelerating drug discovery and materials design to revolutionizing software engineering and agricultural biotechnology, the versatile applications of generative biology are poised to reshape the global landscape of innovation. The report delves into the historical development of generative biology, outlining the core computational techniques that are powering this revolution, including generative models, design optimization algorithms, computational biology approaches, and data-driven methodologies. It analyzes the key market drivers, such as the increasing demand for efficient and cost-effective product development, the rise in investment and funding, and the convergence of generative biology with other emerging technologies.

Providing a detailed competitive landscape, the report examines the diverse ecosystem of technology companies, start-ups, and research institutions shaping the global generative biology market. It also presents a comprehensive segmentation of the market, highlighting the growth trajectories across various technologies, applications, end-user industries, and geographic regions. The wide-ranging applications of generative biology are explored, showcasing how these transformative techniques are being applied to accelerate drug discovery, design advanced materials, engineer synthetic biological systems, optimize software architectures, and address challenges in agriculture and environmental remediation.

The report presents a detailed market map, highlighting the diverse ecosystem of technology companies, start-ups, and research institutions that are shaping the competitive landscape. It analyzes the key market drivers, such as the advancements in computational techniques and the growing recognition of generative biology's potential across various industries. Segmentation of the global generative biology market is provided across multiple dimensions, including technology (e.g., deep learning, evolutionary algorithms, agent-based modeling), application (e.g., drug discovery, materials design, synthetic biology, software engineering), end-user industry (e.g., pharmaceuticals, chemicals, technology, agriculture), and geographic regions (North America, Europe, Asia-Pacific, Rest of the World).

The report also delves into the market challenges and limitations, addressing concerns related to data availability, computational resources, regulatory considerations, and ethical implications surrounding the development and deployment of generative biology technologies. The report explores the transformative applications of generative biology across a wide range of industries, providing in-depth analysis and case studies. In the pharmaceuticals and biotechnology sector, generative biology techniques are revolutionizing drug discovery and development, protein engineering, synthetic biology, and personalized medicine. The report examines how these computational approaches are accelerating the identification of novel drug candidates, optimizing therapeutic molecules, and enabling the engineering of advanced biotherapeutics and cellular systems. In the chemicals and materials industry, generative biology is driving the discovery of novel materials, the optimization of material properties, and the development of intelligent and adaptive materials systems. The report highlights the integration of generative models, high-throughput experimentation, and multi-objective optimization to streamline the design and commercialization of innovative materials. The application of generative biology in software engineering and design is explored, showcasing how these techniques are being leveraged to optimize software architectures, generate algorithms and code, and create adaptive and self-organizing software solutions. The report also delves into the transformative impact of generative biology in the agriculture and environmental sectors, including crop engineering, microbial engineering, bioremediation, and the development of advanced biosensing systems. Furthermore, the report examines the emerging applications of generative biology in other industries, such as aerospace, energy, consumer goods, intelligent systems, and finance, highlighting the cross-pollination of ideas and the potential for broader societal impact.

The report provides a comprehensive market forecast for the global generative biology market, projecting a compound annual growth rate (CAGR) of 25-30% from 2024 to 2035. This growth trajectory is driven by the continued advancements in computational techniques, the increasing adoption across diverse industries, and the convergence of generative biology with other emerging technologies. Detailed market size and forecast data are presented, segmented by technology, application, end-user industry, and geographic region. The report identifies the key growth opportunities and strategic recommendations for market players to capitalize on the expanding generative biology landscape.

The report profiles 97 companies and innovative start-ups shaping the global generative biology market, including technology giants, specialized software providers, and pioneering biotechnology firms. It analyzes the strategic initiatives, product offerings, and financial performance of these key market players, providing valuable insights into the competitive dynamics and growth strategies within the industry. Companies profiled include Absci, BigHat Biosciences, BioAge Labs, Bioptimus, Cradle, Deepcell, Evozyne, Generate:Biomedicines, Iambic Therapeutics, Insilico Medicine, Leash Biosciences, Model Medicines, Noetik, Profluent Bio, Terray Therapeutics, Xaira and Yoneda Labs (Full list in table of contents).

1. RESEARCH METHODOLOGY

2. INTRODUCTION

2.1. What is generative biology?
2.2. Historical development
2.3. Key techniques
- 2.3.1. Generative Models
  - 2.3.1.1. Generative Adversarial Networks (GANs)
  - 2.3.1.2. Variational Autoencoders (VAEs)
  - 2.3.1.3. Normalizing Flows
  - 2.3.1.4. Autoregressive Models
  - 2.3.1.5. Evolutionary Generative Models
- 2.3.2. Design Optimization
  - 2.3.2.1. Evolutionary Algorithms (e.g., Genetic Algorithms, Evolutionary Strategies)
  - 2.3.2.2. Reinforcement Learning
  - 2.3.2.3. Multi-Objective Optimization
  - 2.3.2.4. Bayesian Optimization
- 2.3.3. Computational Biology
  - 2.3.3.1. Molecular Dynamics Simulations
  - 2.3.3.2. Quantum Mechanical Calculations
  - 2.3.3.3. Systems Biology Modeling
  - 2.3.3.4. Metabolic Engineering Modeling
- 2.3.4. Data-Driven Approaches
  - 2.3.4.1. Machine Learning
  - 2.3.4.2. Graph Neural Networks
  - 2.3.4.3. Unsupervised Learning
  - 2.3.4.4. Active Learning and Bayesian Optimization
- 2.3.5. Agent-Based Modeling
- 2.3.6. Hybrid Approaches

3. MARKET ANALYSIS

3.1. Market drivers
3.2. Market map and competitive landscape
3.3. Investment in generative biology
3.4. Industry collaborations
3.5. Market challenges
3.6. Application Areas
- 3.6.1. Drug discovery and development
  - 3.6.1.1. Proteins
  - 3.6.1.2. New therapeutic small molecules
  - 3.6.1.3. RNA therapeutics
  - 3.6.1.4. Protein degraders
  - 3.6.1.5. Other Emerging Areas
- 3.6.2. Materials design and optimization
  - 3.6.2.1. Novel Materials Discovery
  - 3.6.2.2. Materials Optimization
  - 3.6.2.3. Materials Simulation and Modeling
  - 3.6.2.4. High-Throughput Screening and Experimentation
  - 3.6.2.5. Materials-by-Design
  - 3.6.2.6. Intelligent Materials Systems
- 3.6.3. Synthetic biology
  - 3.6.3.1. Genetic Circuit Design
  - 3.6.3.2. Metabolic Pathway Engineering
  - 3.6.3.3. Whole-Cell Modelling and Design
  - 3.6.3.4. Directed Evolution and Protein Engineering
  - 3.6.3.5. Synthetic Ecology and Microbiome Engineering
  - 3.6.3.6. Automated Design and Prototyping
- 3.6.4. Software engineering and design
  - 3.6.4.1. Software Architecture Design
  - 3.6.4.2. Algorithm and Code Generation
  - 3.6.4.3. Adaptive and Self-Organizing Software
  - 3.6.4.4. Software Product Lines and Variability Management
  - 3.6.4.5. Human-Computer Interaction and User Experience Design
- 3.6.5. Agricultural biotechnology and bioremediation
  - 3.6.5.1. Crop Engineering
  - 3.6.5.2. Microbial Engineering for Agriculture
  - 3.6.5.3. Biofertilizer and Biopesticide Development
  - 3.6.5.4. Bioremediation and Environmental Restoration
  - 3.6.5.5. Biomass and Biofuel Production
  - 3.6.5.6. Biosensing and Monitoring
3.7. End use markets
- 3.7.1. Pharmaceuticals and biotechnology
  - 3.7.1.1. Drug Discovery and Development
  - 3.7.1.2. Protein Engineering and Biotherapeutics
  - 3.7.1.3. Synthetic Biology and Cellular Engineering
  - 3.7.1.4. Precision Medicine and Personalized Therapeutics
  - 3.7.1.5. SWOT analysis
  - 3.7.1.6. Key market players
- 3.7.2. Chemicals and materials
  - 3.7.2.1. Novel Materials Discovery
  - 3.7.2.2. Materials Optimization
  - 3.7.2.3. High-Throughput Screening and Experimentation
  - 3.7.2.4. Materials-by-Design
  - 3.7.2.5. Intelligent and Adaptive Materials
  - 3.7.2.6. SWOT analysis
  - 3.7.2.7. Key market players
- 3.7.3. Technology and software
  - 3.7.3.1. Software Architecture Design
  - 3.7.3.2. Algorithm and Code Generation
  - 3.7.3.3. Software Optimization and Refactoring
  - 3.7.3.4. Adaptive and Self-Organizing Software
  - 3.7.3.5. Software Product Lines and Variability Management
  - 3.7.3.6. Human-Computer Interaction and User Experience Design
  - 3.7.3.7. SWOT analysis
  - 3.7.3.8. Key market players
- 3.7.4. Agriculture and environment
  - 3.7.4.1. Crop Engineering
  - 3.7.4.2. Microbial Engineering for Agriculture
  - 3.7.4.3. Biofertilizer and Biopesticide Development
  - 3.7.4.4. Bioremediation and Environmental Restoration
  - 3.7.4.5. Biomass and Biofuel Production
  - 3.7.4.6. Biosensing and Monitoring
  - 3.7.4.7. SWOT analysis
  - 3.7.4.8. Key market players
- 3.7.5. Other industries
  - 3.7.5.1. Aerospace and Defense
  - 3.7.5.2. Energy and Sustainability
  - 3.7.5.3. Consumer Goods and Manufacturing
  - 3.7.5.4. Intelligent Systems and Robotics
3.8. Market Size and Forecast, 2020-2035 (USD Billion)
- 3.8.1. By Technology
- 3.8.2. By Application
- 3.8.3. By End-User Industry
- 3.8.4. By Geographic Regions

4. COMPANY PROFILES

4.1. Absci Corp
4.2. AI Proteins
4.3. Alto Neuroscience
4.4. Amgen
4.5. Amply Discovery
4.6. AQEMIA
4.7. Amphista Therapeutics
4.8. AstraZeneca
4.9. Arzeda
4.10. Athos Therapeutics
4.11. Atomwise
4.12. Aurigene Pharmaceutical Services
4.13. Avicenna Biosciences
4.14. Basecamp Research
4.15. BenevolentAI
4.16. BigHat Biosciences
4.17. BioAge Labs
4.18. Biolexis Therapeutics
4.19. BioMap
4.20. Biomatter Designs
4.21. BioPhy
4.22. Bioptimus SAS
4.23. Cambrium GmbH
4.24. Century Health Technology, Inc.
4.25. Cradle
4.26. Deepcell
4.27. DeepCure
4.28. Deep Genomics
4.29. Design Therapeutics
4.30. Diagonal Therapeutics
4.31. Diffuse Bio
4.32. Etcembly
4.33. Evaxion Biotech A/S
4.34. Evozyne
4.35. Exscientia
4.36. Genie TechBio
4.37. Gene2Lead
4.38. Generate:Biomedicines
4.39. Genesis Therapeutics
4.40. Gero
4.41. GlaxoSmithKline (GSK)
4.42. Google Deepmind
4.43. Healx
4.44. Iambic Therapeutics
4.45. Ibex Medical Analytics
4.46. Idoven
4.47. Iktos
4.48. Inceptive
4.49. Insilico Medicine
4.50. Insitro
4.51. Isomorphic Laboratories
4.52. Integrated Biosciences
4.53. Kuano
4.54. Leash Biosciences
4.55. Mana.bio
4.56. Medeloop
4.57. Menten AI
4.58. MiLaboratories, Inc.
4.59. Model Medicines
4.60. Molecular Quantum Solutions
4.61. Nabla Bio
4.62. Noetik
4.63. Nobias Therapeutics
4.64. Novo Nordisk
4.65. Nucleai
4.66. NVIDIA
4.67. Odyssey Therapeutics
4.68. Orbital Materials
4.69. Ordaos Bio
4.70. Owkin
4.71. Perpetual Medicines
4.72. Polaris Quantum Biotech (POLARISqb)
4.73. PredxBio
4.74. Profluent Bio
4.75. ProPhase Labs
4.76. ProteinQure
4.77. QuantHealth
4.78. Recursion Pharmaceuticals
4.79. Relay Therapeutics
4.80. Roche
4.81. Roivant Sciences
4.82. Sanofi
4.83. Schrodinger
4.84. Seismic Therapeutic
4.85. SimBioSys
4.86. Superluminal Medicines
4.87. T-Cypher Bio
4.88. Ten63 Therapeutics
4.89. Terray Therapeutics
4.90. TRexBio
4.91. Valo Health
4.92. VantAI
4.93. Verge Genomics
4.94. Xaira Therapeutics
4.95. Xtalpi
4.96. Yoneda Labs
4.97. Zephyr AI

5. GLOSSARY

6. REFERENCES

List of Tables

Table 1. Key techniques in generative biology
Table 2. Market drivers for generative biology
Table 3. Generative biology investments 2020-2024
Table 4. Industry collaborations in generative biology
Table 5. Generative biology market challenges and limitations
Table 6. Comparison of synthetic biology and genetic engineering
Table 7. Applications of Generative Biology Across Key Markets
Table 8. Generative biology in drug discovery and development
Table 9. Generative biology in protein engineering and biotherapeutics
Table 10. Generative biology in synthetic biology and cellular engineering
Table 11. Generative biology in precision medicine and personalized therapeutics,
Table 12. Key market players in Generative biology in Pharmaceuticals and Biotechnology
Table 13. Generative biology in chemicals and materials
Table 14. Key market players in Generative biology in Chemicals and materials
Table 15. Applications of generative biology in software optimization and refactoring
Table 16. Key market players in Generative biology in Technology and software
Table 17. Key market players in Generative biology in Agriculture and environment
Table 18. Generative biology in aerospace and defence
Table 19. Generative biology applications in energy and sustainability
Table 20. Generative biology applications in consumer goods and manufacturing
Table 21. Generative biology applications in intelligent systems and robotics
Table 22. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by technology, Conservative Estimate
Table 23. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by technology, Optimistic Estimate
Table 24. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by application, Conservative Estimate
Table 25. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by application, Optimistic Estimate
Table 26. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by End-User Industry, Conservative Estimate
Table 27. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by End-User Industry, Optimistic Estimate
Table 28. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by Region, Conservative Estimate
Table 29. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by Region, Optimistic Estimate
Table 30. Glossary of terms

List of Figures

Figure 1. The design-make-test-learn loop of generative biology
Figure 2. Historical development of generative biology
Figure 3. Market map for generative biology
Figure 4. Investment in generative biology 2020-2024 (Millions USD)
Figure 7. The composition of human proteins
Figure 8. SWOT analysis: Generative biology in Pharmaceuticals and Biotechnology
Figure 9. SWOT analysis: Generative biology in Chemicals and materials
Figure 10. SWOT analysis: Generative biology in Technology and software
Figure 11. SWOT analysis: Generative biology in Agriculture and environment
Figure 12.Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by technology, Conservative Estimate
Figure 13. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by technology, Optimistic Estimate
Figure 14. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by application, Conservative Estimate
Figure 15. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by application, Optimistic Estimate
Figure 16. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by End-User Industry, Conservative Estimate
Figure 17. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by End-User Industry, Optimistic Estimate
Figure 18. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by Region, Conservative Estimate
Figure 19. Global Generative Biology Market Size and Forecast, 2020-2035 (USD Billion), by Region, Optimistic Estimate
Figure 20. XtalPi's automated and robot-run workstations

The Global Market for Generative Biology 2024-2035

Description

Table of Contents

List of Tables

TABLE OF CONTENTS

1. RESEARCH METHODOLOGY

2. INTRODUCTION

3. MARKET ANALYSIS

4. COMPANY PROFILES

5. GLOSSARY

6. REFERENCES

List of Tables

List of Figures